Salicylic Acid

Description

No description information is available for the specified drug.

Uses and Indications

This drug is indicated for the removal of common and plantar warts. Common warts are characterized by their rough, 'cauliflower-like' surface appearance, while plantar warts are specifically located on the bottom of the foot and disrupt the normal footprint pattern.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

The affected area should be washed thoroughly, and warts may be soaked in warm water for approximately 5 minutes to facilitate treatment. After soaking, the area must be dried completely. A small amount of the wart remover should then be applied using the provided applicator, ensuring that each wart is sufficiently covered.

This application should be allowed to dry, and the procedure may be repeated once or twice daily. Treatment can continue until the wart is removed, with a maximum duration of up to 12 weeks.

Contraindications

Use of this product is contraindicated in the following situations:

Patients with diabetes or poor blood circulation should not use this product except under the advice and supervision of a healthcare professional, such as a doctor or podiatrist, due to the increased risk of complications.

The product should not be applied to genital warts or warts located on the face, as these areas may require specialized treatment.

Application is also contraindicated on moles, birthmarks, and warts with hair growing from them, as these may indicate underlying conditions that necessitate caution.

The product must not be used on mucous membranes, as this can lead to irritation or adverse reactions.

Additionally, it is contraindicated for use on irritated, infected, or reddened skin, as this may exacerbate existing conditions or lead to further complications.

Warnings and Precautions

For external use only, this product is flammable and should be kept away from fire or flame. It is essential to cap the bottle tightly and store it at room temperature, away from heat sources.

This product is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the advice and supervision of a healthcare professional, such as a doctor or podiatrist. It should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it must not be used on mucous membranes or on skin that is irritated, infected, or reddened.

When using this product, care should be taken to avoid contact with the eyes. In the event of contact, the eyes should be flushed with water for at least 15 minutes. Inhalation of vapors should also be avoided.

If discomfort persists, the user should discontinue use and consult a healthcare professional. This product should be kept out of reach of children. In the case of accidental ingestion, immediate medical assistance should be sought or contact with a Poison Control Center should be made.

Side Effects

Patients should be aware that this product is for external use only. It is contraindicated for individuals who are diabetic or have poor blood circulation, unless used under the advice and supervision of a doctor or podiatrist. The product should not be applied to genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. Additionally, it should not be used on mucous membranes or on irritated, infected, or reddened skin.

During use, patients should take care to avoid contact with the eyes. In the event that the product comes into contact with the eyes, it is recommended to flush the eyes with water for 15 minutes. Patients should also avoid inhaling vapors from the product.

Patients are advised to discontinue use and consult a doctor if discomfort persists. It is important to keep this product out of reach of children. In case of accidental ingestion, medical help should be sought immediately, or contact a Poison Control Center without delay.

Drug Interactions

There are currently no documented drug interactions associated with this medication. Additionally, there is no information available regarding interactions with laboratory tests. As such, no specific recommendations for dosage adjustments or monitoring are warranted at this time.

Packaging & NDC

Below are the non-prescription pack sizes of Salicylic Acid (wart remover liquid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is currently no information available regarding the use of Salicylic Acid Wart Remover Liquid during pregnancy. This includes a lack of data on safety concerns, dosage modifications, or any special precautions that should be taken when considering its use in pregnant patients. Healthcare professionals are advised to exercise caution and consider the potential risks versus benefits when prescribing this product to women of childbearing potential. Further studies may be necessary to fully understand the implications of Salicylic Acid Wart Remover Liquid on fetal outcomes.

Lactation

There is no specific information regarding nursing mothers or lactation considerations provided in the drug insert for Salicylic Acid Wart Remover Liquid. Therefore, the effects on breastfed infants and the excretion of the drug in breast milk remain unknown. Healthcare professionals should exercise caution and consider the potential risks versus benefits when recommending this product to lactating mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the prescribing information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous evaluation and appropriate interventions should be implemented based on the clinical presentation and severity of symptoms.

In all cases of suspected overdosage, the involvement of poison control experts is recommended to guide treatment decisions and ensure optimal patient care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this product out of reach of children to prevent accidental ingestion. In the event of swallowing the product, patients should seek medical help or contact a Poison Control Center immediately.

Patients should be informed that this product is not recommended for use in individuals with diabetes or poor blood circulation unless under the guidance and supervision of a healthcare professional, such as a doctor or podiatrist. Additionally, patients should be cautioned against using the product on genital warts, warts on the face, moles, birthmarks, or warts with hair growing from them. It is also important to instruct patients not to apply the product to mucous membranes or on skin that is irritated, infected, or reddened.

Healthcare providers should emphasize that if discomfort persists after using the product, patients should stop use and consult their doctor. Furthermore, patients should be made aware to avoid contact with their eyes while using the product. In case of accidental exposure to the eyes, they should flush with water for 15 minutes. Lastly, patients should be advised to avoid inhaling vapors from the product to ensure their safety during use.

Storage and Handling

The product is supplied in a tightly capped bottle, which should be stored at room temperature, away from heat sources. It is essential to maintain the storage temperature within the range of 20°C to 30°C (68°F to 86°F). Additionally, it is crucial to keep the product away from fire or flame to ensure safety and integrity.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Salicylic Acid, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)